The history of vaccination against cytomegalovirus

Medical Microbiology and Immunology
Stanley Plotkin

Abstract

Cytomegalovirus vaccine development started in the 1970s with attenuated strains. In the 1980s, one of the strains was shown to be safe and effective in renal transplant patients. Then, attention switched to glycoprotein gB, which was shown to give moderate but transient protection against acquisition of the virus by women. The identification of the pp65 tegument protein as the principal target of cellular immune responses resulted in new approaches, particularly DNA, plasmids to protect hematogenous stem cell recipients. The subsequent discovery of the pentameric protein complex that generates most neutralizing antibodies led to efforts to incorporate that complex into vaccines. At this point, there are many candidate CMV vaccines, including live recombinants, replication-defective virus, DNA plasmids, soluble pentameric proteins, peptides, virus-like particles and vectored envelope proteins.

References

Sep 1, 1975·Infection and Immunity·S A PlotkinC Huygelen
Nov 1, 1976·The Journal of Infectious Diseases·S A PlotkinE Horberger
Jan 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·B J NeffM R Hilleman
Aug 1, 1985·The Journal of Infectious Diseases·S A Plotkin, E S Huang
May 1, 1986·Journal of Virology·E GönczölS A Plotkin
Oct 10, 1986·JAMA : the Journal of the American Medical Association·S StagnoC A Alford
Apr 1, 1982·American Journal of Diseases of Children·G R FleisherS A Plotkin
May 1, 1983·The Journal of Infectious Diseases·W P CarneyS A Plotkin
Apr 16, 1998·The Pediatric Infectious Disease Journal·S P AdlerS Riddell
Sep 9, 1999·The Journal of Infectious Diseases·R F PassR L Burke
Feb 13, 2002·The Pediatric Infectious Disease Journal·Douglas K MitchellStuart P Adler
Aug 30, 2002·Seminars in Pediatric Infectious Diseases·Robert F Pass, Rae Lyn Burke
Dec 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Dai Wang, Thomas Shenk
Jan 3, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mark A JacobsonStuart P Adler
Apr 19, 2006·The Journal of Infectious Diseases·Thomas C HeinemanGeorge Kemble
Nov 8, 2007·Annals of the New York Academy of Sciences·Sven KochGraham Pawelec
Dec 19, 2007·Medical Microbiology and Immunology·Monto Ho
May 1, 2008·The Journal of Infectious Diseases·Mary K WlochMichael Boeckh
Mar 20, 2009·The New England Journal of Medicine·Robert F PassGretchen Cloud
May 16, 2009·Critical Care : the Official Journal of the Critical Care Forum·Ryosuke Osawa, Nina Singh
May 15, 2010·Infectious Disease Clinics of North America·Per LjungmanMichael Boeckh
Aug 9, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Emilia GeniniGiuseppe Gerna

❮ Previous
Next ❯

Citations

Dec 4, 2015·International Journal of Environmental Research and Public Health·Alexia WillameBegoña Martinez de Tejada
Jul 17, 2015·PLoS Pathogens·Simone ThomasNiels A W Lemmermann
May 20, 2016·Medical Microbiology and Immunology·Eugenia Corrales-AguilarHartmut Hengel
Nov 4, 2016·Medical Microbiology and Immunology·Bodo Plachter
Feb 9, 2016·The Lancet. Haematology·Michael Boeckh, Peter B Gilbert
Oct 18, 2016·Preventive Medicine Reports·Rosemary Thackeray, Brianna M Magnusson
Nov 1, 2016·Science Translational Medicine·Dai WangTong-Ming Fu
Nov 1, 2016·Expert Review of Hematology·Franco LocatelliPietro Merli
Aug 16, 2016·The Journal of Infectious Diseases·Gail J Demmler Harrison
Jun 26, 2017·The Journal of Infection·Charlene M C RodriguesStanley A Plotkin
Nov 14, 2017·Viral Immunology·Stanley A Plotkin
Aug 8, 2017·Science Immunology·Sumana ChandramouliAndrea Carfi
Sep 25, 2018·Expert Review of Vaccines·Don Jeffrey DiamondJohn A Zaia
May 21, 2019·The Journal of Infectious Diseases·Frances M SaccoccioSallie R Permar
Jun 22, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Kenneth De BaetsPhilip C J Donoghue
Mar 7, 2020·The Journal of Infectious Diseases·Tatiana M LanzieriStanley A Plotkin
Jul 25, 2020·The Journal of Infectious Diseases·Maria E HasingJutta K Preiksaitis
Jul 25, 2017·Medical Microbiology and Immunology·Vera SeidelKatharina Weizsäcker
Nov 25, 2016·Drugs·K M AnderholmM R Schleiss
Jun 6, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gaëlle Picarda, Chris A Benedict
Jul 5, 2018·Medical Microbiology and Immunology·Annemarie Berger, Hans Wilhelm Doerr
May 2, 2018·Proceedings of the National Academy of Sciences of the United States of America·Cody S NelsonSallie R Permar
Sep 28, 2017·PLoS Computational Biology·Michiel van BovenDebbie van Baarle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Mark R Schleiss
Reviews of Infectious Diseases
Stanley PlotkinK Brayman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Michael A McVoy
© 2021 Meta ULC. All rights reserved